WallStreetZenWallStreetZen

NASDAQ: ENVB
Enveric Biosciences Inc Stock

$1.55-0.11 (-6.63%)
Updated Mar 4, 2024
ENVB Price
$1.55
Fair Value Price
N/A
Market Cap
$3.60M
52 Week Low
$0.65
52 Week High
$6.98
P/E
-0.13x
P/B
1.48x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$22.53M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.72
Operating Cash Flow
-$16M
Beta
1.11
Next Earnings
Mar 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ENVB Overview

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ENVB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENVB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ENVB is good value based on its book value relative to its share price (1.48x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
ENVB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ENVB due diligence checks available for Premium users.

Be the first to know about important ENVB news, forecast changes, insider trades & much more!

ENVB News

Valuation

ENVB fair value

Fair Value of ENVB stock based on Discounted Cash Flow (DCF)
Price
$1.55
Fair Value
$6.92
Undervalued by
77.62%
ENVB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ENVB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.13x
Industry
15.95x
Market
36.03x

ENVB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.48x
Industry
6.2x
ENVB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENVB's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.8M
Profit Margin
0%
ENVB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.6M
Liabilities
$4.2M
Debt to equity
1.72
ENVB's short-term assets ($5.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENVB's short-term assets ($5.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENVB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ENVB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.7M
Investing
$20.0
Financing
-$105.0k
ENVB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ENVB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ENVB$3.60M-6.63%-0.13x1.48x
ONCO$3.60M+4.89%-0.18x0.35x
PALI$3.67M-2.45%0.97x0.26x
AVTX$3.69M+4.07%-0.01x0.25x
KTRA$3.71M-5.94%-0.02x-22.61x

Enveric Biosciences Stock FAQ

What is Enveric Biosciences's quote symbol?

(NASDAQ: ENVB) Enveric Biosciences trades on the NASDAQ under the ticker symbol ENVB. Enveric Biosciences stock quotes can also be displayed as NASDAQ: ENVB.

If you're new to stock investing, here's how to buy Enveric Biosciences stock.

What is the 52 week high and low for Enveric Biosciences (NASDAQ: ENVB)?

(NASDAQ: ENVB) Enveric Biosciences's 52-week high was $6.98, and its 52-week low was $0.65. It is currently -77.79% from its 52-week high and 138.83% from its 52-week low.

How much is Enveric Biosciences stock worth today?

(NASDAQ: ENVB) Enveric Biosciences currently has 2,321,315 outstanding shares. With Enveric Biosciences stock trading at $1.55 per share, the total value of Enveric Biosciences stock (market capitalization) is $3.60M.

Enveric Biosciences stock was originally listed at a price of $43,500.00 in Nov 16, 2017. If you had invested in Enveric Biosciences stock at $43,500.00, your return over the last 6 years would have been -100%, for an annualized return of -81.86% (not including any dividends or dividend reinvestments).

How much is Enveric Biosciences's stock price per share?

(NASDAQ: ENVB) Enveric Biosciences stock price per share is $1.55 today (as of Mar 4, 2024).

What is Enveric Biosciences's Market Cap?

(NASDAQ: ENVB) Enveric Biosciences's market cap is $3.60M, as of Mar 5, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enveric Biosciences's market cap is calculated by multiplying ENVB's current stock price of $1.55 by ENVB's total outstanding shares of 2,321,315.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.